Angela Mirarchi

Dr. Angela Mirarchi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
AMAngela Mirarchi
Angela Mirarchi
Rosario MareRosario Mare
Rosario Mare
VMVincenzo Musolino
Vincenzo Musolino
SNSaverio Nucera
Saverio Nucera
VMVincenzo Mollace
Vincenzo Mollace
SMSamantha Maurotti
Samantha Maurotti
Background: Bergamot polyphenolic fraction (PF) extract exerts a beneficial against liver steatosis. However, the fundamental processes underlying this beneficial effect of bergamot PF remain elusive. In this work, we examined the effect of bergamot PF extract on 2D and 3D hepatocyte cultures. Material and Methods: We evaluated the effect of bergamot PF in 2D and 3D cultures from rat, human hepatoma cells, and human primary hepatocytes. Results: In 2D cell culture, we demonstrated that incubation with bergamot PF decreases intracellular lipid content and is associated with an increase in expression levels of ß-oxidation genes (Acox1, Pparα, and Ucp2) and lipophagy (Atg7). Moreover, we confirm this effect on 3D spheroids and organoids. Conclusion: Incubation with bergamot PF reduces intracellular lipid neutral fat potentially by increasing intracellular pathways related to beta-oxidation.

20 December 2021 in Medicina
Verified
Journal Article
Open access
PDF file
Yvelise FerroYvelise Ferro
Yvelise Ferro
RPRoberta Pujia
Roberta Pujia
SMSamantha Maurotti
Samantha Maurotti
GBGiada Boragina
Giada Boragina
AMAngela Mirarchi
Angela Mirarchi
EMElisa Mazza
Elisa Mazza
Mediterranean Diet represents the traditional eating habits of populations living around the Mediterranean Sea, and it is associated with a lower risk of overall mortality and cancer incidence and cardiovascular diseases. Severe acute respiratory syndrome coronavirus 2 is a new pandemic, and represents a significant and critical threat to global human health. In this study, we aimed to review the possible effects of Mediterranean Diet against the risk of the coronavirus disease 2019. Several vitamins, minerals, fatty acids, and phytochemicals with their potential anti-COVID-19 activity are presented. Different risk factors may increase or reduce the probability of contracting the disease. Mediterranean Diet has also a positive action on inflammation and immune system and could have a protective effect against severe acute respiratory syndrome coronavirus 2. Further studies are needed to corroborate the benefits of the Mediterranean Diet protective role on infection with SARS-CoV-2.

1 May 2024 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
GPGrazia Pennisi
Grazia Pennisi
SMSamantha Maurotti
Samantha Maurotti
ECEster Ciociola
Ester Ciociola
OJOveis Jamialahmadi
Oveis Jamialahmadi
GBGiorgio Bertolazzi
Giorgio Bertolazzi
SRStefano Romeo
Stefano Romeo
BACKGROUND: ANGPTL3 (angiopoietin-like protein 3) is a circulating protein with a key role in maintaining lipoprotein homeostasis. A monoclonal antibody against ANGPTL3 is an approved and well-tolerated treatment to reduce lipoproteins in familial hypercholesterolemia homozygotes. However, the reduction of hepatic ANGPTL3 synthesis using an antisense oligonucleotide unexpectedly resulted in a dose-dependent increase in liver lipid content and circulating transaminases, resulting in the termination of the clinical trial. Meanwhile, the use of silencing RNAs remains an area of active investigation. Our study sought to investigate whether intracellular downregulation of ANGPTL3 may lead to a primary increase in neutral lipids within the hepatocyte. METHODS: We downregulated ANGPTL3 by silencing RNA in primary human hepatocytes 3-dimensional spheroids, HepG2/LX-2 3-dimensional spheroids, and in HepG2, Hep3B2, and Huh7 cultured in 2 dimensions. RESULTS: ANGPTL3 downregulation increased neutral lipids in all models investigated. Interestingly, ANGPTL3 induced lower intracellular deiodinase type 1 protein levels resulting in a reduction in beta-oxidation and causing an increase in triglycerides stored in lipid droplets. CONCLUSIONS: In conclusion, intracellular ANGPTL3 downregulation by silencing RNA led to an increase in triglycerides content due to a reduction in energy substrate utilization resembling a primary intracellular hepatocyte hypothyroidism.

16 October 2025 in Molecular and Cellular Endocrinology
Verified
Journal Article
Open access
SMS. Maurotti
S. Maurotti
BSBernadette Scopacasa
Bernadette Scopacasa
Francesca SciontiFrancesca Scionti
Francesca Scionti
RPR. Pujia
R. Pujia
MFM. Frosina
M. Frosina
APA. Pujia
A. Pujia
Primary hypothyroidism has been associated with metabolic dysfunction-associated steatotic liver disease and, potentially, increased liver fibrosis risk. Although T4-analog drug is one of the standard treatments, its molecular effects on the liver are not fully understood. To elucidate drug-induced hepatic metabolic changes, chronic human 2D and 3D hypothyroid models were developed. The effects of T4 were assessed by Raman spectroscopy and complementary biological techniques to observe lipid and fibrotic changes. In vitro chronic hypothyroidism caused lipid droplet (LDs) accumulation in liver cells which was unaffected by T4 therapy. Notably, TSH and T4 influenced TG fatty acid saturation in different ways: T4-exposed cells accumulated monounsaturated fatty acids at the expense of saturated fatty acids. In the case of liver fibrosis, TSH treatment activated hepatic stellate cells as evidenced by increased collagen secretion and decreased LD content, regardless of T4 co-treatment. Data confirmed that TSH induced pro-inflammatory changes leading to higher inflammasome levels in a 3D liver model. These findings indicate the detrimental effects of elevated TSH levels, and it is worth noting that T4 administration does not reverse the excess of hepatic lipid overload but has the ability to alter its lipid composition. Furthermore, T4 administration did not reverse TSH-induced hepatic fibrogenesis in the hypothyroid cell models. Because micro-Raman spectroscopy is currently restricted to 2D/3D in-vitro systems, further validation in intact tissue and in vivo is warranted. In conclusion, our results highlight the importance of further research into the molecular pathways associated with chronic liver injury in patients with chronic hypothyroidism.

12 December 2025 in Applied Food Research
Verified
Journal Article
Open access
Rosario MareRosario Mare
Rosario Mare
AVA. Verardi
A. Verardi
MSM. Settino
M. Settino
AMAngela Mirarchi
Angela Mirarchi
SGS. Greco
S. Greco
APA. Pujia
A. Pujia

10 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Francesca SciontiFrancesca Scionti
Francesca Scionti
SMSamantha Maurotti
Samantha Maurotti
EMElisa Mazza
Elisa Mazza
AMAngela Mirarchi
Angela Mirarchi
RRRaffaella Russo
Raffaella Russo
APArturo Pujia
Arturo Pujia
Background: Diet quality significantly influences metabolic health, obesity, and non-communicable disease risk. Functional foods and nutraceuticals, rich in bioactive compounds, may enhance health outcomes beyond basic nutrition, particularly when combined with Mediterranean-style dietary patterns. Objectives: This feasibility study evaluated the integration of functional foods and nutraceuticals into a Mediterranean-based dietary intervention in adults with metabolic risk factors, focusing on feasibility, tolerability, and preliminary clinical effects. Methods: Functional food prototypes, including Calabrian tomato, pomegranate, bergamot, blueberry, and hazelnut products, along with two nutraceutical formulations, were developed, characterized for bioactive content, and assessed for palatability, bioavailability, and safety. Adults aged ≥50 years participated in a 4-week intervention, consuming daily servings of functional foods and either a whey protein-based or essential amino acid-based nutraceutical. Compliance, acceptability, anthropometry, body composition, muscle strength, and biochemical markers were assessed pre- and post-intervention. Results: Functional foods and nutraceuticals were well-tolerated, with high adherence (>80%). Bioactive compounds were detectable in serum post-consumption, confirming bioavailability. Preliminary findings suggested that integrating functional foods and nutraceuticals into a Mediterranean-style dietary intervention is feasible, safe, and acceptable in older adults with metabolic risk factors. These results support the potential clinical benefit of combined dietary strategies and provide a rationale for a larger randomized controlled trial to evaluate efficacy on metabolic, musculoskeletal, and hepatic outcomes.